Search

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas

First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas

First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas

Collaboration key to meeting consumers’ expectations for better animal welfare

Collaboration key to meeting consumers’ expectations for better animal welfare

Collaboration key to meeting consumers’ expectations for better animal welfare

Dr. André Desrochers named as the 2019 Metacam® 20* Bovine Welfare Award winner

Dr. André Desrochers named as the 2019 Metacam® 20* Bovine Welfare Award winner

Dr. André Desrochers named as the 2019 Metacam® 20* Bovine Welfare Award winner

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development